TEI Biosciences Inc. Company Profile

12:44 EST 22nd December 2014 | BioPortfolio

A Boston-based, privately-held, leading biomedical company, TEI Biosciences Inc. has applied its expertise in regenerative medicine to develop and commercialize novel biologic products for a broad spectrum of soft tissue repair, regeneration, and reinforcement applications -- from plastic and reconstructive surgery to dura, tendon, and hernia repair, and wound management.


News Articles [664 Associated News Articles listed on BioPortfolio]

Marck Biosciences Ltd - Company Capsule

Recently added to the BioPortfolio report store, Marck Biosciences Ltd - Company Capsule is a new report from ICD Research published on 2011-11-16. This 8-page report is available from $75. ICD Res...

Coherus BioSciences: Coherus BioSciences to Present at the J.P. Morgan Healthcare Conference on January 12

REDWOOD CITY, Calif., 2014-12-08 15:00 CET (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), a late-stage clinical biologics platform company focused on the global biosimilar market, tod...

Coherus BioSciences: Coherus BioSciences to Host Earnings Conference Call on December 15

REDWOOD CITY, Calif., 2014-12-04 22:05 CET (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), a late-stage clinical biologics platform company focused on the global biosimilar market, tod...

Powertech to Distribute Pressure BioSciences' Lab Tools in China

Powertech Technology, a distributor of laboratory tools based in Xiamen, signed a three-year agreement to distribute Pressure BioSciences' products in China. Pressure BioSciences makes constant and al...

Regado Biosciences permanently halts REGULATE-PCI trial

US-based cardiovascular specialist Regado Biosciences Regado Biosciences has announced the permanent termination of enrollment in its REGULATE-PCI Phase III trial for its lead program, Revolixys Kit.

Neurocrine Biosciences, Inc. To Present At The Biotechnology Conference

SAN DIEGO, Nov. 3, 2014 /PRNewswire/ --Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presentin...

Neurocrine Biosciences, Inc. To Present At The 2014 Deutsche Bank Biofest And The 26th Annual Piper Jaffray Healthcare Conference

SAN DIEGO, Nov. 25, 2014 /PRNewswire/ --Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenti...

Daiichi Sankyo pays $410m for Ambit Biosciences

Daiichi Sankyo has bought San Diego-based Ambit Biosciences in a deal aimed at shoring up the Japanese company’s cancer research. Daiichi says in a statement that it will acquire all of the outstand...

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Companies [302 Associated Companies listed on BioPortfolio]

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Valent BioSciences Corporation

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and co...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

DaVinci Biosciences LLC

DaVinci Biosciences LLC is a privately held company dedicated to advancing therapies that improve the quality of life for individuals suffering from trauma, disease and degenerative disorders. Through...

BD Biosciences Bioimaging

BD Biosciences Bioimaging gives "sight" to computers, by creating software that captures images from digital cameras and extracts information from those images. We integrate our software into high-per...

More Information about "TEI Biosciences Inc." on BioPortfolio

We have published hundreds of TEI Biosciences Inc. news stories on BioPortfolio along with dozens of TEI Biosciences Inc. Clinical Trials and PubMed Articles about TEI Biosciences Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TEI Biosciences Inc. Companies in our database. You can also find out about relevant TEI Biosciences Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Rheumatology
Latest News Clinical Trials Research Drugs Reports Corporate
Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Dictionary). It is an active area of medical research, because of the d...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record